Vault-13

Defilade Capital Management, L.P.

EMERYVILLE, CA · CIK 2088557 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2025 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Emeryville, CA (main office)United States United Statesabout 4
Pensacola, FLUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$746.9m reported value +4.9% vs Q1 2026
39positions
46.5%in top 10
20 new 8 added 10 reduced 12 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ELI LILLY & CO COM LLY LLY 39,086 $46.9m6.28% 6.28% AddedShares held: Q3 2025 —, Q4 2025 31.9k, Q1 2026 20.7k, Q2 2026 39.1k +18.4k +18,390 88.9%
2 PFIZER INC COM PFE PFE 1,771,743 $42.7m5.71% 5.71% AddedShares held: Q3 2025 —, Q4 2025 2.2m, Q1 2026 1.5m, Q2 2026 1.8m +307.6k +307,614 21.0%
3 VEEVA SYS INC CL A COM VEEV VEEV 236,709 $42.0m5.62% 5.62% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 236.7k
4 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 682,005 $39.0m5.22% 5.22% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 682.0k
5 PTC THERAPEUTICS INC COM PTCT PTCT 433,699 $35.4m4.74% 4.74% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 376.2k, Q2 2026 433.7k +57.5k +57,534 15.3%
6 BAXTER INTL INC COM BAX BAX 1,459,380 $31.1m4.17% 4.17% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.5m
7 INSMED INC COM PAR $.01 INSM INSM 281,838 $30.0m4.02% 4.02% AddedShares held: Q3 2025 —, Q4 2025 50.0k, Q1 2026 194.9k, Q2 2026 281.8k +86.9k +86,929 44.6%
8 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 317,426 $27.3m3.66% 3.66% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 579.2k, Q2 2026 317.4k -261.7k -261,735 -45.2%
9 INSULET CORP COM PODD PODD 176,932 $26.9m3.61% 3.61% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 176.9k
10 THERMO FISHER SCIENTIFIC INC COM TMO TMO 51,934 $26.0m3.49% 3.49% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 51.9k
11 ABBOTT LABS COM ABT ABT 285,778 $25.9m3.47% 3.47% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 285.8k
12 ASCENDIS PHARMA A/S ORD SHS ASND ASND 94,843 $25.3m3.39% 3.39% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 94.8k
13 SOLVENTUM CORP COM SHS SOLV SOLV 316,454 $24.4m3.27% 3.27% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 316.5k
14 MEDTRONIC PLC SHS MDT MDT 303,301 $23.7m3.18% 3.18% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 303.3k
15 ELANCO ANIMAL HEALTH INC COM ELAN ELAN 864,080 $21.3m2.85% 2.85% ReducedShares held: Q3 2025 —, Q4 2025 401.3k, Q1 2026 931.1k, Q2 2026 864.1k -67.0k -67,041 -7.2%
16 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 546,848 $20.3m2.72% 2.72% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 546.8k
17 ENVISTA HOLDINGS CORPORATION COM NVST NVST 726,108 $19.1m2.56% 2.56% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 726.1k
18 REVOLUTION MEDICINES INC COM RVMD RVMD 82,827 $15.5m2.08% 2.08% ReducedShares held: Q3 2025 —, Q4 2025 363.5k, Q1 2026 316.0k, Q2 2026 82.8k -233.1k -233,145 -73.8%
19 ICU MED INC COM ICUI ICUI 105,700 $15.5m2.07% 2.07% ReducedShares held: Q3 2025 —, Q4 2025 340.7k, Q1 2026 254.3k, Q2 2026 105.7k -148.6k -148,591 -58.4%
20 COGENT BIOSCIENCES INC COM COGT COGT 393,441 $15.2m2.04% 2.04% AddedShares held: Q3 2025 —, Q4 2025 568.6k, Q1 2026 352.6k, Q2 2026 393.4k +40.9k +40,851 11.6%
21 LANTHEUS HLDGS INC COM LNTH LNTH 132,662 $14.7m1.97% 1.97% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 249.4k, Q2 2026 132.7k -116.7k -116,739 -46.8%
22 OCULAR THERAPEUTIX INC COM OCUL OCUL 1,490,286 $14.6m1.96% 1.96% AddedShares held: Q3 2025 —, Q4 2025 681.7k, Q1 2026 1.5m, Q2 2026 1.5m +2.6k +2,641 0.2%
23 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 3,525,338 $13.9m1.86% 1.86% ReducedShares held: Q3 2025 —, Q4 2025 3.3m, Q1 2026 3.6m, Q2 2026 3.5m -38.8k -38,789 -1.1%
24 TYRA BIOSCIENCES INC COM TYRA TYRA 376,870 $12.0m1.61% 1.61% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 376.9k
25 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 924,758 $11.6m1.55% 1.55% ReducedShares held: Q3 2025 —, Q4 2025 1.2m, Q1 2026 1.5m, Q2 2026 924.8k -579.8k -579,778 -38.5%
26 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,047,690 $11.3m1.52% 1.52% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 842.9k, Q2 2026 1.0m +204.8k +204,762 24.3%
27 LARIMAR THERAPEUTICS INC COM LRMR LRMR 3,670,135 $11.2m1.50% 1.50% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 3.7m
28 GLOBUS MED INC CL A GMED GMED 139,637 $11.0m1.48% 1.48% ReducedShares held: Q3 2025 —, Q4 2025 267.2k, Q1 2026 354.4k, Q2 2026 139.6k -214.7k -214,713 -60.6%
29 ENOVIS CORPORATION COM ENOV ENOV 531,945 $11.0m1.47% 1.47% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 531.9k
30 EVOMMUNE INC COM SHS EVMN EVMN 793,145 $10.5m1.41% 1.41% AddedShares held: Q3 2025 —, Q4 2025 215.4k, Q1 2026 678.6k, Q2 2026 793.1k +114.6k +114,556 16.9%
31 TELEFLEX INCORPORATED COM TFX TFX 80,118 $10.2m1.36% 1.36% NewShares held: Q3 2025 —, Q4 2025 42.9k, Q1 2026 0, Q2 2026 80.1k
32 DENALI THERAPEUTICS INC COM DNLI DNLI 391,866 $10.1m1.35% 1.35% ReducedShares held: Q3 2025 —, Q4 2025 656.7k, Q1 2026 1.4m, Q2 2026 391.9k -968.1k -968,103 -71.2%
33 GLAUKOS CORP COM GKOS GKOS 66,519 $9.3m1.24% 1.24% NewShares held: Q3 2025 —, Q4 2025 91.7k, Q1 2026 0, Q2 2026 66.5k
34 STAAR SURGICAL CO COM PAR $0.01 STAA STAA 322,126 $9.2m1.24% 1.24% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 322.1k
35 PACS GROUP INC COM SHS PACS PACS 215,675 $9.2m1.23% 1.23% ReducedShares held: Q3 2025 —, Q4 2025 1.1m, Q1 2026 604.2k, Q2 2026 215.7k -388.5k -388,505 -64.3%
36 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 239,440 $9.0m1.20% 1.20% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 239.4k
37 LIVANOVA PLC SHS LIVN LIVN 107,373 $8.8m1.18% 1.18% NewShares held: Q3 2025 —, Q4 2025 241.4k, Q1 2026 0, Q2 2026 107.4k
38 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 1,674,999 $3.1m0.41% 0.41% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.7m
39 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 7,558,756 $2.4m0.32% 0.32% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 7.6m, Q2 2026 7.6m

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
HENRY SCHEIN INC HSIC HSIC 624,037 $46.0m624.0k shares
BECTON DICKINSON & CO BDX BDX 279,210 $43.9m279.2k shares
DEXCOM INC DXCM DXCM 538,762 $33.8m538.8k shares
INTUITIVE SURGICAL INC ISRG ISRG 67,681 $31.2m67.7k shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 209,932 $27.7m209.9k shares
INTEGER HLDGS CORP ITGR ITGR 213,027 $18.7m213.0k shares
BIOGEN INC BIIB BIIB 96,289 $17.7m96.3k shares
TANDEM DIABETES CARE INC TNDM TNDM 761,905 $14.6m761.9k shares
NUVALENT INC 129,950 $13.3m129.9k shares
ASCENDIS PHARMA A/S 51,895 $11.9m51.9k shares
ALIGN TECHNOLOGY INC ALGN ALGN 67,332 $11.5m67.3k shares
BIOHAVEN LTD BHVN BHVN 315,944 $2.7m315.9k shares